Literature DB >> 30022454

Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease.

Sumedha V Chablani1, Claudia Ramos-Rivers2, David G Binion2, Eva Szigethy3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30022454     DOI: 10.1007/s10620-018-5194-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

1.  Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home.

Authors:  Miguel Regueiro; Benjamin Click; Alyce Anderson; William Shrank; Jane Kogan; Sandra McAnallen; Eva Szigethy
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-12       Impact factor: 11.382

2.  Constructing an Inflammatory Bowel Disease Patient-Centered Medical Home.

Authors:  Miguel Regueiro; Benjamin Click; Diane Holder; William Shrank; Sandra McAnallen; Eva Szigethy
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-16       Impact factor: 11.382

3.  Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease.

Authors:  Sumedha V Chablani; Claudia Ramos-Rivers; David G Binion; Eva Szigethy
Journal:  Dig Dis Sci       Date:  2018-07-19       Impact factor: 3.199

4.  Depression Is Associated With More Aggressive Inflammatory Bowel Disease.

Authors:  Bharati Kochar; Edward L Barnes; Millie D Long; Kelly C Cushing; Joseph Galanko; Christopher F Martin; Laura E Raffals; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2017-11-14       Impact factor: 10.864

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 6.  White Paper AGA: The Impact of Mental and Psychosocial Factors on the Care of Patients With Inflammatory Bowel Disease.

Authors:  Eva M Szigethy; John I Allen; Marci Reiss; Wendy Cohen; Lilani P Perera; Lili Brillstein; Raymond K Cross; David A Schwartz; Lawrence R Kosinski; Joshua B Colton; Elizabeth LaRusso; Ashish Atreja; Miguel D Regueiro
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-12       Impact factor: 11.382

7.  Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease.

Authors:  A N Ananthakrishnan; V S Gainer; R G Perez; T Cai; S-C Cheng; G Savova; P Chen; P Szolovits; Z Xia; P L De Jager; S Y Shaw; S Churchill; E W Karlson; I Kohane; R H Perlis; R M Plenge; S N Murphy; K P Liao
Journal:  Aliment Pharmacol Ther       Date:  2013-01-07       Impact factor: 8.171

8.  Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.

Authors:  Alyce J M Anderson; Benjamin Click; Claudia Ramos-Rivers; Dmitriy Babichenko; Ioannis E Koutroubakis; Douglas J Hartman; Jana G Hashash; Marc Schwartz; Jason Swoger; Arthur M Barrie; Michael A Dunn; Miguel Regueiro; David G Binion
Journal:  Dig Dis Sci       Date:  2016-09-12       Impact factor: 3.199

9.  Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

Authors:  Christian Mittermaier; Clemens Dejaco; Thomas Waldhoer; Anna Oefferlbauer-Ernst; Wolfgang Miehsler; Markus Beier; Wolfgang Tillinger; Alfred Gangl; Gabriele Moser
Journal:  Psychosom Med       Date:  2004 Jan-Feb       Impact factor: 4.312

10.  Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.

Authors:  Alexis Calloway; Robin Dalal; Dawn B Beaulieu; Caroline Duley; Kimberly Annis; Lawrence Gaines; Chris Slaughter; David A Schwartz; Sara Horst
Journal:  Dig Dis Sci       Date:  2017-10-20       Impact factor: 3.199

View more
  1 in total

1.  Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease.

Authors:  Sumedha V Chablani; Claudia Ramos-Rivers; David G Binion; Eva Szigethy
Journal:  Dig Dis Sci       Date:  2018-07-19       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.